Tuesday, March 18, 2025
Home 2020

Yearly Archives: 2020

Athersys, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Adding Organicell (BPSR) $0.02 to the Watch List.

Editor / Curator -
America BriVision, Biotech Stock Review
Incubator

Adding American BriVision (ABVC) $2.00 to Watch List.

Editor / Curator -
Biotech News

Athersys (ATHX) Overview and Due Diligence links (Reddit)

Editor / Curator -
Internet Stock Review
Stand Down.

Immunomedics (IMMU) up 100% Today or $2 Billion in Value &...

Editor / Curator -
Biotech Stock Review, Novellus, Citius
Biotech News

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS)...

Editor / Curator -
Superbug News - CoronaVirus Watch List

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and...

Editor / Curator -
OMNIQ
Cybersecurity

OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.

Editor / Curator -
All News

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was...

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Editor / Curator -
1...151617...20Page 16 of 20

Latest article

Zomedica (ZOMDF) Surges 40% Higher, Friday.

Uncategorized Editor / Curator -
Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.